Nuvo Pharmaceuticals Completes Previously Announced Acquisition of Aralez’ Revenue-Generating Products

Nuvo Pharmaceuticals, a Canadian healthcare firm, has completed the acquisition of a portfolio of more than 20 revenue-generating products of Aralez Pharmaceuticals. Earlier, the news of Nuvo having a conference call/audio webcast on January 2, 2019, at 8:30 a.m. EST was released. The call was about providing the details of the transaction, Aralez’s key products, …

Walgreens Boots Alliance to Take Part in the Credit Suisse Conference of Healthcare

The Walgreens Boots Alliance has announced that company leaders including Global Chief Financial Officer and Executive Vice President James Kehoe will be taking part in the 27th Annual Healthcare Conference of Credit Suisse on Wednesday November 14, at The Phoenician, in Scottsdale Arizona. The audio feed for the appearance of the Walgreens Boots Alliance representative …

Discovering Possibilities to Treat Huntington’s Disease

Medical science has been successful in various aspects in terms of treating diseases that had no cure earlier. Similar dilemma was being experienced with the process of finding a possible treatment for neurodegenerative diseases. Even after achieving advancement in the various genetic diseases, researchers have repeatedly failed to taste success in case of Huntington’s disease. …